论文部分内容阅读
目的探讨结直肠癌伴肠系膜肿瘤结节对患者预后的影响。方法回顾性分析124例结直肠癌患者临床资料,分为肠系膜肿瘤结节组16例和不伴有肠系膜肿瘤结节组108例,两组患者均进行Dukes’分期,对比分析生存率并评价预后。结果肠系膜肿瘤结节组患者总5年生存率为31.25%,不伴有肠系膜肿瘤结节组为75.00%,两组比较,差异有统计学意义(P<0.05)。肠系膜肿瘤结节组患者在Dukes’A期、B期5年生存率分别为0%和50.0%,不伴有肠系膜肿瘤结节组分别为93.99%和93.18%,差异均有统计学意义(P<0.05),肠系膜肿瘤结节组患者在Dukes’C期、D期5年生存率分别为50.00%和14.29%,不伴有肠系膜肿瘤结节组分别为67.57%和8.33%,两组比较,差异无统计学意义(P>0.05)。伴有肠系膜肿瘤结节患者的Dukes’A+B期患者5年生存率为50.0%,与Dukes’C期67.57%比较,差异无统计学意义(P>0.05)。结论结直肠癌伴有肠系膜肿瘤结节患者预后不良,其临床意义更类似于淋巴结转移。
Objective To investigate the prognosis of patients with colorectal cancer and mesenteric tumor nodules. Methods A retrospective analysis of 124 patients with colorectal cancer clinical data, divided into mesenteric tumor nodules in 16 patients and non-mesenteric tumor nodules in 108 patients, both groups were Dukes’ stage, comparative analysis of survival rate and evaluation of prognosis . Results The overall 5-year survival rate was 31.25% in patients with mesenteric tumor nodules and 75.00% in patients without mesenteric tumor nodules. There was significant difference between the two groups (P <0.05). The 5-year survival rates of patients with mesenteric tumor nodules in Dukes’A and B were 0% and 50.0%, respectively, and those in patients without mesenteric neoplasia were 93.99% and 93.18%, respectively, with significant difference (P <0.05). The 5-year survival rates of patients with mesenteric tumor nodules in Dukes’C stage and D stage were 50.00% and 14.29%, respectively, and those without mesenteric tumor nodules were 67.57% and 8.33% respectively. The difference was not statistically significant (P> 0.05). The 5-year survival rate of Dukes’A + B patients with mesenteric tumor nodules was 50.0%, which was not significantly different from Dukes’C 67.57% (P> 0.05). Conclusions Patients with colorectal cancer with mesenteric tumor nodules have poor prognosis, and their clinical significance is more similar to lymph node metastasis.